Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03668067 · ClinicalTrials.gov registry record
Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines
A clinical trial, sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 471
- Enrollment target
NCT03668067 is a clinical trial that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 471 participants.
The verdict
NCT03668067 has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
Pediatric eye patients receive infrared photoscreener screening and skiascopy as a part of routine examination to compare ability to detect amblyopia risk factors.
Interventions
- DEVICE 2WIN photoscreener
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2018-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03668067
The ClinicalTrials.gov registry entry for NCT03668067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alaska Blind Child Discovery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2WIN photoscreener is the first listed.
NCT03668067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03668067 about?
NCT03668067 is a clinical study titled "Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines". Pediatric eye patients receive infrared photoscreener screening and skiascopy as a part of routine examination to compare ability to detect amblyopia risk factors.
What is the current status of trial NCT03668067?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2018-04-02. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03668067?
The interventions under investigation include: 2WIN photoscreener (DEVICE).
Who is sponsoring clinical trial NCT03668067?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.